• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Cells Release Insulin in Response to Music

      Cells Release Insulin in Response to Music

    • Radiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

    • Cardiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Photonic Radar Monitors Breathing from a Distance

      Photonic Radar Monitors Breathing from a Distance

    • Surgery
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Optical Strain Sensors for Rehab

      Optical Strain Sensors for Rehab

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Brain Computer Interface Decodes Speech and Facial Expressions

      Brain Computer Interface Decodes Speech and Facial Expressions

      Semi-Automated Manufacture of E-Skin Sensors

      Semi-Automated Manufacture of E-Skin Sensors

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Global Cancer Janus Kinase Inhibitors Market Opportunity and Clinical Trial Insight 2023

January 11th, 2018 Kuick Research Releases

For Report Sample Contact: neeraj@kuickresearch.com

 

Report Weblink: https://www.kuickresearch.com/report-global-cancer-janus-kinase-inhibitors-market-opportunity-and-clinical-trial-insight-2023.php

 

Table of Contents

 

1. Prologue to JAK/STAT Pathway

  1.1 Overview

  1.2 Categorization of JAK/STAT Inhibitors in Cancer Therapeutics

2. Role of JAK/STAT Pathway in Tumor Formation

3. JAK/STAT Inhibitors: Modern Therapeutics for Effective Cancer Management

4. Understanding the Targets for Inhibition: An Insight into JAK and STAT Proteins

  4.1 Structure and Significance

    4.1.1 Janus Kinases: A Novel Cytokine Receptor

    4.1.2 STAT Proteins: The Signal Generators for Transcription

  4.2 Importance of Modulation of JAK/STAT in a Healthy Cell

5. Mechanism of Action of JAK/STAT Inhibitors

6. Identification of Active Target in Tumor Cells for JAK/STAT Inhibition

  6.1 Cell Based Assays

  6.2 Biochemical Assays

7. Need and Superiority of JAK/STAT Inhibitors: Its Importance in Modern Cancer Therapy

8. JAK/STAT Inhibitors in Cancer Therapy

  8.1 Hematological Malignancies

    8.1.1 Myelofibrosis

    8.1.2 Acute Lymphoblastic Leukemia

    8.1.3 Polycythemia Vera

    8.1.4 Primary thrombocythemia

  8.2 Solid Tumors

    8.2.1 Lung Cancer

    8.2.2 Ovarian Cancer

    8.2.3 Breast Cancer

    8.2.4 Pancreatic Cancer

    8.2.5 Hepatocellular Carcinoma

    8.2.6 Colorectal cancer

    8.2.7 Head and Neck Squamous Cell Carcinoma

    8.2.8 Prostate Cancer

    8.2.9 Glioblastoma

    8.2.10 Other Solid Tumors

9. Cancer JAK/STAT Inhibitor Drugs

  9.1 Approved Drugs

    9.1.1 Ruxolitinib

  9.2 Promising Candidates in the Clinical Pipeline

    9.2.1 Momelotinib

    9.2.2 Lestaurtinib

    9.2.3 Pacritinib

10. Global Cancer JAK/STAT Inhibitor Market Outlook

  10.1 Current Scenario

  10.2 Clinical Pipeline Overview

11. Global Cancer JAK/STAT Inhibitor Therapy Price Analysis

  11.1 Analyzing the Cost of Available JAK/STAT Inhibitor

  11.2 Comparative Price Analysis of JAK/STAT Inhibitors and Best Available Therapy

  11.3 Comparative Price Analysis of JAK/STAT Inhibitors and Conventional Cancer Therapies

  11.4 Comparative Price Analysis of JAK/STAT Inhibitors and Newly Approved Anti-Cancer Therapeutics

12. Global Cancer JAK/STAT Inhibitor Market Dynamics

  12.1 Favorable Factors for Cancer JAK/STAT Inhibitors Market

    12.1.1 Elevation in Disease Burden

    12.1.2 Unmet Medical Need

    12.1.3 Advancement in Technology

    12.1.4 Strong Clinical Pipeline

    12.1.5 Orphan Drug Status to JAK/STAT Inhibitors

    12.1.6 Commercial Success of Ruxolitinib

  12.2 Market challenges for Cancer JAK/STAT Inhibitors

    12.2.1 Scientific Limitations and the Number of Side Effects

    12.2.2 Clinical Hold on Pacritinib

    12.2.3 Tedious approval process

13. Global Cancer JAK/STAT Inhibitor Market Future Outlook

14. Global Cancer Janus Kinase Inhibitors Clinical Pipeline by Company and Phase

  14.1 Research

  14.2 Preclinical

  14.3 Phase-I

  14.4 Phase-I/II

  14.5 Phase-II

  14.6 Phase-III

  14.7 Preregistration

15. Marketed Cancer Janus Kinase Inhibitors Clinical Insight by Company

  15.1 Ruxolitinib (Jakafi and Jakavi)

16. Suspended Cancer Janus Kinase Inhibitors in Clinical Pipeline by Company and Phase

  16.1 No Development Reported

  16.2 Discontinued

17. Competitive Landscape

  17.1 Abbott Laboratories

  17.2 Asana Biosciences

  17.3 Astra Zeneca

  17.4 Celon Pharmaceuticals

  17.5 Dynamic Pharma

  17.6 Eli Lilly

  17.7 Gilead Sciences

  17.8 Hanmi Pharmaceuticals

  17.9 Incyte

  17.10 Kyowa Hakko

  17.11 Moleculin

  17.12 Pfizer

  17.13 PIQUR Therapeutics

  17.14 Portola Pharmaceuticals

  17.15 S*BIO

 

Figure 1-1: Conventional Approaches for Treating Cancer

Figure 1-2: Major Limitations of Conventional Cancer Therapies

Figure 1-3: Modern Approach in Cancer Therapy

Figure 1-4: Major Types of Cancer Treatment Modalities

Figure 1-5: Categorization of JAK Inhibitors in Targeted Therapies

Figure 3-1: Advanced Approaches for the Development of JAK/STAT Inhibitors

Figure 4-1: Architecture of the Structure of Janus Kinase

Figure 4-2: Cis Mode of Activation of Janus Kinase

Figure 4-3: Trans Mode of Activation of Janus Kinase

Figure 4-4: Architecture of the Structure of STAT Proteins

Figure 4-5: Activation of STAT Proteins

Figure 4-6: Natural Inhibitors of JAK/STAT Signaling Pathway

Figure 5-1: JAK/STAT Signaling Pathway in Normal Human Cell

Figure 5-2: JAK/STAT Pathway in Hematological Cancers

Figure 5-3: Mechanism of Action of JAK inhibitors

Figure 6-1: Technologies Used For Diagnosing JAK/STAT Pathway in Tumor Cells

Figure 7-1: Advanced Features of JAK/STAT Inhibitors in Cancer Therapy

Figure 8-1: JAK/STAT Mutations in Hematological Malignancies

Figure 9-1: Target and Effects of Ruxolitinib

Figure 9-2: Impact of Ruxolitinib on Change in Mean Spleen Size

Figure 10-1: Global Prevalence – Myelofibrosis Patients (Numbers), 2015-17

Figure 10-2: Global Prevalence – Polycythemia Vera Patients (Numbers), 2015-17

Figure 10-3 Global Prevalence – Primary Thrombocythemia Patients (Numbers), 2015-17

Figure 10-4 : Global- Ruxolitinib Revenue for Myelofibrosis (US$ Million), 2015-2017

Figure 10-5: Global – Ruxolitinib Revenue for Polycythemia Vera (US$ Million), 2015-2017

Figure 10-6: Global- Ruxolitinib Revenue for Primary Thrombocythemia (US$ Million), 2015-2017

Figure 10-7: Global- Ruxolitinib Revenue by Hematological Malignancies (%), 2016

Figure 10-8: Global Janus Kinase Inhibitors Cancer Clinical Pipeline by Phase (%), 2017 till 2023

Figure 10-9: Global Janus Kinase Inhibitors Cancer Clinical Pipeline by Phase (Number), 2017 till 2023

Figure 10-10: Global Janus Kinase Inhibitors Cancer Clinical Pipeline by Phase (%), 2017 till 2023

Figure 10-11: Global Janus Kinase Inhibitors Cancer Clinical Pipeline by Phase (Number), 2017 till 2023

Figure 11-1: Ruxolitinib andndash; Average Per Tablet and Packet Cost Analysis (US$)

Figure 11-2: Ruxolitinib andndash; Average and Lifetime Treatment Cost Analysis (US$)

Figure 11-3: Global- Average Price of Ruxolitinib Treatment (US$/Month), 2015-2017

Figure 11-4: Survival Rate of Myelofibrosis Patients Undergoing Ruxolitinib Treatment v/s Best Available Therapy

Figure 11-5: Global – Average Lifetime Expenditure of Myelofibrosis Patient (US$)

Figure 11-6: Global – Average Lifetime Drug and Resource Cost (US$)

Figure 11-7: Global – Average Cost of Complete Treatment of Myelofibrosis Patient (US$)

Figure 11-8: Quality Adjusted Life Years for Ruxolitinib and Best Available Therapy for Myelofibrosis

Figure 11-9: Average Cost of JAK/STAT Inhibitors and Conventional Therapies for Cancer (US$/Month)

Figure 11-10: Complete Treatment Cost of JAK/STAT Inhibitors and Monoclonal Antibody Drug (US$)

Figure 11-11: Treatment Cost of JAK/STAT Inhibitors and CAR-T Cell Therapy for Cancer (US$)

Figure 11-12: Treatment Cost of JAK/STAT Inhibitors and Other Small Molecule Cancer Drugs (US$)

Figure 12-1: Global andndash; Cancer JAK/STAT Inhibitor Market Drivers

Figure 12-2: Global – Challenges for Cancer JAK/STAT Inhibitors Market

Figure 13-1: Global- Cancer JAK/STAT Inhibitors Market Opportunity (US$ Billion), 2018-2023

Table 2-1: JAK Mutations in Cancers

Table 2-2: STAT Mutations in Cancers

Table 11-1: Ruxolitinib Price Analysis

 

Sign up and submit a press release

Sponsored
Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Viral Vector Manufacturing in Gene Therapy and Vaccine Development

Health and Clean Air: Why Indoor Ventilation Matters

Health and Clean Air: Why Indoor Ventilation Matters

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

MedTech Outlook 2023 for Latin America Released

MedTech Outlook 2023 for Latin America Released

interviews & reviews
Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email